Physician profile
Thomas Hodo
NPI 1760976203
$4,375.32
in general payments reported to CMS, 2019-2025
9 companies · $2,177 in 2025
The $2,177 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,056 · 2023: $179 · 2024: $963 · 2025: $2,177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,050 · Travel and Lodging: $1,269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,050.02 |
| Travel and Lodging | $1,269.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,780.99 | 2022-2024 | Mako, Gmrs, Insignia |
| Zimmer Biomet Holdings, INC. | $1,474.60 | 2025 | |
| Onkos Surgical, INC. | $326.34 | 2024-2025 | Eleos Limb Salvage System |
| Innovation Technologies INC | $210.01 | 2024 | Irrisept |
| Integrum INC. | $171.98 | 2025 | Opra Implant System |
| Medtronic, INC. | $153.37 | 2025 | Osteocool Rf Ablation System |
| Medical Device Business Services, INC. | $109.03 | 2025 | Emphasys |
| Convatec INC. | $95.84 | 2023 | |
| Illuminoss Medical, INC. | $53.16 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hodo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.